Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia: Post-approval THERMOCOOL VT trial

Keyphrases

• 3-year Survival 16%
• Adverse Event Rates 16%
• Adverse Events 16%
• Amiodarone 50%
• Anxiety Scale 33%
• Coronary Disease 16%
• Days of Treatment 16%
• Depression Scale 33%
• Hospital Anxiety 33%
• Hospitalization 50%
• Implantable Cardioverter-defibrillator 16%
• Implantable Cardioverter-defibrillator Shock 33%
• Length of Hospital Stay 16%
• Long-term Efficacy 16%
• Long-term Safety 16%
• Post-approval Changes 100%
• Pre-ablation 16%
• Quality of Life 16%
• Quality of Life Improvement 16%
• Radiofrequency Catheter Ablation 100%
• Recurrent Ventricular Tachycardia 16%
• Sustained Ventricular Tachycardia 100%
• Ventricular Tachycardia 100%
• Ventricular Tachycardia Recurrence 33%

Medicine and Dentistry

• Adverse Event 28%
• Amiodarone 42%
• Cardiovascular System 28%
• Coronary Artery Disease 14%
• Hospital Anxiety and Depression Scale 28%
• Implantable Automatic Defibrillator 42%
• Ischemic Heart Disease 14%
• Long-Term Outcome 14%
• Monomorphic Ventricular Tachycardia 42%
• Quality of Life 28%
• Recurrent Disease 42%
• Sustained Ventricular Tachycardia 100%
• Ventricular Tachycardia 100%

Nursing and Health Professions

• Accident Prevention 12%
• Adverse Event 25%
• Amiodarone 37%
• Cardiovascular System 25%
• Catheter 12%
• Coronary Artery Disease 12%
• Heart Ventricle Tachycardia 100%
• Hospital Anxiety and Depression Scale 25%
• Implantable Cardioverter Defibrillator 37%
• Ischemic Heart Disease 12%
• Monomorphic Ventricular Tachycardia 37%
• Quality of Life 25%
• Recurrent Disease 37%